Table 4.
Relationships between regional lean mass and BMD at spine (L2-L4) and hip at baseline (A) and correlation of % changes from baseline after 12-months Degarelix treatment (B)
| a | ||
|---|---|---|
| BMD L2-L4 | BMD LEFT HIP | |
| Arm Lean (g) | .106 | .543* |
| Leg Lean (g) | .256 | .688* |
| Trunk Lean (g) | .449 * | .754* |
| Arm Fat (g) | .181 | .449* |
| Leg Fat (g) | .175 | .507* |
| Trunk Fat (g) | .140 | .551* |
| b | ||
|---|---|---|
| BMD L2-L4 (% changes) | BMD LEFT HIP (% changes) | |
| Arm Lean (% changes) | .107 | − .172 |
| Leg Lean (% changes) | − .154 | .098 |
| Trunk Lean (% changes) | .163 | − .221 |
| Arm Fat (% changes) | − .301 | .181 |
| Leg Fat (% changes) | − .231 | .212 |
| Trunk Fat (% changes) | − .271 | .127 |
Data are Spearman R
BMD bone mineral density
*Significant relationships